Trends in the incidence and morbidity of Merkel cell carcinoma in Brazil.

Future Oncol

Division of Clinical Research & Technological Development, Brazilian National Cancer Institute (INCA), André Cavalcanti St, 37, 5th floor Centro, Rio de Janeiro, 20231-050, Brazil.

Published: August 2021

The current study aims to present epidemiologic changes and clinical aspects of Merkel cell carcinoma (MCC) in Brazil. Data were collected from the Brazilian Population-Based Cancer Registries (2000-2015) and Hospital-Based Cancer Registries (2000-2017). The average age-standardized incidence rates significantly increased in men between the years 2000 (0.31/1,000,000) and 2015 (1.21/1,000,000), with an annual percentage change of 9.4 (95% CI: 4.7-14.4; p < 0.001). In women, the incidence rates rose insignificantly in the period with an annual percentage change of 3.1 (95% CI: 0.0-6.2; p < 0.10). From the hospital-based database, 881 MCC patients were identified. Most of the patients were females (51.2%), aged >60 years (82.2%), White (67.6%) and diagnosed at stages III or IV (50.5%). A key aspect of public health promotion is to understand the incidence and morbidity of MCC.

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2020-1313DOI Listing

Publication Analysis

Top Keywords

merkel cell
8
cell carcinoma
8
cancer registries
8
trends incidence
4
incidence morbidity
4
morbidity merkel
4
carcinoma brazil
4
brazil current
4
current study
4
study aims
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!